… of QR-010. Horizon 2020 is one of the largest research and innovation programs in the European Union with nearly €80 … the European Research Council, the European Institute of Innovation and Technology and EURATOM and evaluates projects …
… during the Foundation Fighting Blindness/Casey Innovation summit Appointed ADAR expert Dr. Peter A. Beal to … candidates and the timing thereof, including those in our innovation pipeline, the potential of our Axiomer ® …
… from the European Union’s Horizon 2020 research and innovation programme. Clinical trial PQ-010-002 top-line data … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About … candidates and the timing thereof, including those in our innovation pipeline, statements regarding release of clinical …
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active treatment and sham eyes to their corresponding contralateral eyes across multiple endpoints – Company plans to discuss findings with regulators in Q3
… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About … candidates and the timing thereof, including those in our innovation pipeline, statements regarding release of clinical …
… additional tranches totaling €1.6 million under the Innovation credit program or “Innovatiekrediet” by the Dutch … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… behind the CF and LCA 10 programs from ProQR’s internal innovation (discovery) unit. The clinical program for QR-313 … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About … candidates and the timing thereof, including those in our innovation pipeline and the potential of our Axiomer ® …